[HTML][HTML] Loss of 11p11 is a frequent and early event in sporadic nonfunctioning pancreatic neuroendocrine neoplasms

SP Haugvik, L Gorunova, L Haugom… - Oncology …, 2014 - spandidos-publications.com
The pathogenesis of sporadic pancreatic neuroendocrine neoplasms (PNENs) is poorly
understood. To gain insight into the genetic mechanisms underlying this tumor entity, we …

[引用][C] YY1 在胰岛素瘤中的表达及意义

李雯霞, 黄业恩, 石晓欣, 林佩欣, 邹振宁, 张耀忠… - 南方医科大学学报, 2016

Genomic landscape in gastroenteropancreatic neuroendocrine neoplasms and its usefulness in improving the prognostic evaluation

I Marinoni, AM Schmitt, A Di Domenico… - Diagnostic …, 2018 - Elsevier
Gastroenteropancreatic neuroendocrine tumors (GEP-NET) are a heterogenous group of
tumors with Pancreatic and Small intestinal NET (PanNET and Si-NET) representing most of …

Neuroendocrine Tumors of the Pancreas: Molecular Pathogenesis and Perspectives on Targeted Therapies

IV Maev, DN Andreev… - Journal of Cancer …, 2014 - neoplasiaresearch.com
Pancreatic neuroendocrine tumors (PNETs) are a heterogeneous group of neoplasms that
are the second most common among pancreatic neoplasms. Treatment of PNETs appears to …

[引用][C] 胰腺导管腺癌与非功能胰岛细胞瘤的临床对比分析

徐军辉, 丁佑铭, 汪斌, 付海峰, 徐彦哲 - 临床外科杂志, 2014

[引用][C] 病例分析在常染色体遗传病讲授中的效果评价

王晓玲 - 基础医学教育, 2014

Neuroendocrine neoplasms of the small intestine

S Seydafkan, D Coppola - … Tumors: Review of Pathology, Molecular and …, 2016 - Springer
Small intestine neuroendocrine neoplasms (SI-NENs) derive from enterochromaffin (EC)
cells of the embryonic neural crest and anatomically have been categorized under the …

Evolution of clinical ideas about Zollinger-Ellison syndrome

IV Maev, DN Andreev, IA Kucheriavyĭ… - Terapevticheskii …, 2014 - journals.eco-vector.com
The paper gives the current views of the diagnosis and treatment of Zollinger-Ellison
syndrome (ZES). It underlines the importance of including ZES in differential diagnosis in …

Nonfunctioning Pancreatic Neuroendocrine Tumors

A Koumarianou, N Fazio - Neuroendocrine Tumours: Diagnosis and …, 2015 - Springer
Nonfunctioning pancreatic neuroendocrine tumors are quite rare, representing 2% of all
pancreatic malignancies and 85% of all pancreatic neuroendocrine tumors. They are …

Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

M Andrea, T Weinschenk, O Schoor… - US Patent App. 18 …, 2023 - Google Patents
The present invention relates to peptides, proteins, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the …